Playlist


Ashgabat to Host Gala Concert Featuring Opera Stars from Turkic-Speaking Nations
27 Apr. 04:59On May 2 and 3, Ashgabat will become the epicenter of a major international cultural exchange as it hosts a gala concert dedicated to the 110th anniversary of the legendary Turkmen composer Veli Muhadov. Organized as part of the TÜRKSOY Opera Days, the event will bring together elite performers from across the Turkic world to honor the legacy of a maestro who significantly shaped the region's classical music landscape. This celebration underscores the shared cultural ties and artistic excellence of the participating nations.
The concert will feature distinguished vocalists from Azerbaijan, Kazakhstan, Kyrgyzstan, Uzbekistan, and Turkey, performing alongside the State Symphony Orchestra of Turkmenistan. This collaborative artistic effort aims to showcase a harmonious blend of national operatic traditions and universal classical standards. The participation of international stars highlights the prestige of the event and provides a unique opportunity for cultural dialogue through the universal language of music.
The venue for this high-profile artistic gathering is the Mukams Palace of the State Cultural Center, with performances starting at 6:00 PM. The program is carefully curated to include iconic compositions by Veli Muhadov as well as masterpieces from the global operatic repertoire. By hosting such prestigious events, Ashgabat continues to strengthen its role as a regional hub for the arts and a facilitator of international creative partnerships.
The TÜRKSOY Opera Days in Turkmenistan serve as an important platform for promoting operatic art and fostering professional growth among performers. The anniversary celebrations not only pay tribute to a historical figure in Turkmen music but also illustrate the dynamic development of modern opera in the region. Music enthusiasts and members of the diplomatic community are expected to attend, making it a cornerstone event in the country’s spring cultural calendar.


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
12 Oct. 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.